Inhibition of multidrug resistance by immunisation with synthetic P-glycoprotein-derived peptides.
D018435:ATP Binding Cassette Transporter, Subfamily B; D000818:Animals; D001323:Autoantibodies / Q000276:immunology; D019496:Cancer Vaccines / Q000627:therapeutic use*; D004317:Doxorubicin / Q000627:therapeutic use; D018432:Drug Resistance, Multiple / Q000276:immunology*; D019008:Drug Resistance, Neoplasm / Q000276:immunology*; D005260:Female; D006023:Glycoproteins / Q000276:immunology* / Q000627:therapeutic use; D008050:Lipid A / Q000276:immunology; D008081:Liposomes / Q000276:immunology; D008223:Lymphoma / Q000276:immunology / Q000628:therapy*; D051379:Mice; D014747:Vinblastine / Q000627:therapeutic use
C513055:ABCB1 protein, human; D018435:ATP Binding Cassette Transporter, Subfamily B; D001323:Autoantibodies; D019496:Cancer Vaccines; D006023:Glycoproteins; D008050:Lipid A; D008081:Liposomes; D014747:Vinblastine; D004317:Doxorubicin